Testing Methylphenidate for Smoking Abstinence

NCT00549640 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

80

Enrollment

OTHER

Sponsor class

Conditions

Smoking

Interventions

DRUG: Methylphenidate
DRUG: Placebo

Sponsor

Mayo Clinic

Collaborators

[object Object]